CureVac N.V. (ETR:5CV)
Germany
· Delayed Price · Currency is EUR 2.616
+0.040 (1.55%)
Apr 1, 2025, 10:40 AM CET
CureVac Market Cap
CureVac has a market cap or net worth of €574.87 million as of March 31, 2025. Its market cap has decreased by -16.03% in one year.
Market Cap
574.87M
Enterprise Value
412.81M
Revenue
65.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.62
Market Cap Chart
Since August 14, 2020, CureVac's market cap has decreased from 8.31B to 574.87M, a decrease of -93.09%. That is a compound annual growth rate of -43.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 574.87M | -22.19% |
| Dec 31, 2024 | 738.83M | -13.37% |
| Dec 29, 2023 | 852.88M | -20.54% |
| Dec 30, 2022 | 1.07B | -80.98% |
| Dec 31, 2021 | 5.64B | -51.75% |
| Dec 31, 2020 | 11.69B | 40.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 55.53B |
| Merck KGaA | 55.04B |
| Fresenius SE & Co. KGaA | 22.17B |
| Bayer Aktiengesellschaft | 21.68B |
| Fresenius Medical Care AG | 13.39B |
| Sartorius Aktiengesellschaft | 13.24B |
| Carl Zeiss Meditec AG | 5.30B |
| SCHOTT Pharma AG & Co. KGaA | 3.55B |